Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01974817 · ClinicalTrials.gov registry record · Phase 4
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
A Phase 4 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT01974817 is a Phase 4 study that has completed, run by Michigan State University. The registered enrollment target is 25 participants.
The verdict
NCT01974817, a Phase 4 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the response of 13-valent conjugate pneumococcal vaccine in patients 50 years or older with end stage renal disease on dialysis. The study will also try to determine Streptococcus pneumoniae colonization in patients 50 years or older with end stage renal disease on dialysis.
Interventions
- BIOLOGICAL 13-valent conjugate pneumococcal vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01974817
The ClinicalTrials.gov registry entry for NCT01974817 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 13-valent conjugate pneumococcal vaccine is the first listed.
NCT01974817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01974817 about?
NCT01974817 is a clinical study titled "Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease". The purpose of the study is to determine the response of 13-valent conjugate pneumococcal vaccine in patients 50 years or older with end stage renal disease on dialysis. The study will also try to determine Streptococcus pneumoniae colonization in patients 50 years or older with end stage renal dis...
What is the current status of trial NCT01974817?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2013-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01974817?
The interventions under investigation include: 13-valent conjugate pneumococcal vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01974817?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.